We are an innovative, comprehensive drug testing lab, combining compassionate treatment with state-of-the-art technology to drive the best possible care.
https://t.co/Y39wybAp7E
This cohort study of US adults found an increase in Z-hypnotic and serotonergic drug prescriptions in both men and women along with an increase in benzodiazepine prescriptions in women at the start of the COVID-19 pandemic.
A SAMHSA survey found more than 40 million Americans were living with a substance use disorder in 2020. Learn more about this alarming statistic in the link below.
https://t.co/AHTZY8ck0k
This study published by Pub Med, shows the research priorities for expanding access to methadone treatment for opioid use disorder in the United States. Check it out below!
https://t.co/in4Bf4NGxk
Join ASAM's National Addiction Treatment Week from October 18-24, 2021 to inspire medical professionals to treat addiction and save lives! Take a look at ASAMs training lineup below:
https://t.co/qOvdkZgPTE
"An increasing percentage of emergency visits and hospitalizations in the United States before the pandemic involved patients with alcohol and other substance use disorders, according to a study by UC San Francisco researchers."
https://t.co/F9zz4c21Uo
The CDC released this report about Benzodiazepine-involved overdose deaths decreased during 2017–2019; however, since 2019, the illicit benzodiazepine supply increased. Take a look!
https://t.co/hG6KOXOzw6
"This 50 State Snapshot presents current laws, policies, and court actions related to access to medications for opioid use disorder (MOUD) in correctional facilities in the U.S as of April 2021."
https://t.co/BvdVrzzMkS
Check out this JAMA-published study on the effects of giving high-dosages of Buprenorphine to patients in the ED as a treatment for Opioid Use Disorder. https://t.co/5zz5FyrJCc
New report from the Legal Action Center finds that denying necessary care for Substance Use Disorders in emergency departments can violate federal law. Read more below: https://t.co/0qj0u4gW5n https://t.co/gcdcfQWrs4
https://t.co/yaGTEjxF3M
"Nearly 1 million Americans 65 and older were reported as living with a substance use disorder in 2018, according to federal data. "
https://t.co/CCFMKaGq1L
"Employees are worried about their mental health as they return to the workplace after the COVID-19 pandemic. Stigma can exacerbate their concerns, but employers can thwart its impact."
"The department's findings on Vermont aligned with national trends of elevated substance abuse and mental health challenges during the pandemic."
https://t.co/3c4tegd4F2
https://t.co/TnOmRtvFtS
“We knew we wanted to do something for people, and we knew there had to be a better way to give them access to evidence based-treatment,” says Yusuf Sherwani.
https://t.co/esjkKzUxvn
"Drug overdose deaths rose by close to 30% in the United States in 2020, hitting the highest number ever recorded, the US Centers for Disease Control and Prevention reported."
"As the country opens up, elected officials in West Virginia and Indiana are cracking down on syringe programs even as public health experts plead with them to consider the evidence to the contrary. "
https://t.co/9TNfG32ivN
Learn how integrated screening and treatment for patients with both a mental illness and substance use disorder can make treatment more effective for patients in this short SAMSHA video.
https://t.co/amNNt7aN2g
Have you noticed Aspenti Health's new branding? Aspenti Health is now an Averhealth company; an organization that shares the same ultimate goal of helping individuals with substance use disorder. Learn more about Averhealth in this short video.
https://t.co/s829GIALLl
"Johnson & Johnson has agreed to pay $230 million to New York state to settle claims that the pharmaceutical giant helped fuel the opioid crisis."
https://t.co/9yuYouif1M
https://t.co/wn080sJ68f
Providers specializing in substance abuse care are using telehealth for services like MAT therapy, but the shifting landscape of post-COVID-19 telehealth rules may force them to scale back those plans.